PharmiWeb.com - Global Pharma News & Resources
04-Jan-2021

Medical Technology specialist joins Research Partnership, London

Global healthcare market research consultancy Research Partnership has appointed Hannah Osborn as a MedTech Director in their UK offices in London. Hannah is a seasoned market research professional with over 13 years’ experience in healthcare research and consulting, focusing on medical devices over the past 7 years. She has experience in both qualitative and quantitative methodologies and is most passionate about using her consulting experience to turn data and insights into strategically relevant findings.

Previously Hannah worked for Ipsos as Director of their MedTech APAC team, and for IQVIA as an Engagement Manager leading their medical devices APAC research team.   

Head of MedTech Division, Sabera Hyderally said of her appointment, “I am delighted to welcome Hannah to the MedTech division to expand our business in the EU and APAC. She brings a wealth of experience, deep knowledge and fresh ideas and I’m excited to partner with a researcher of her calibre as we continue our tremendous growth globally.”

Speaking about the appointment, Founding Director Mary Assimakopoulos said, “We are very pleased that Hannah has chosen to join Research Partnership. The MedTech division has seen considerable growth under Sabera’s leadership and Hannah’s appointment further cements the strength of our senior team.”

Media Contact:

Julie Denny,
Marketing Director
julied@researchpartnership.com
T: +44 20 8069 5006

Notes to the editors

About the Research Partnership
We are the largest independent healthcare market research and consulting agency in the world. We collaborate with clients from the global pharmaceutical, MedTech and biotech industries, providing research intelligence and strategic recommendations that elevate healthcare brands and power their success.

www.researchpartnership.com




Medical Technology specialist joins Research Partnership, London

Editor Details

Last Updated: 05-Jan-2021